A review paper published last year in European Journal of Medicinal Chemistry characterized Myc as the “oncogene from ...

A team of researchers at Karolinska Institutet has developed a novel tool for genetic research. The study, published in Nucleic Acids Research ...

Learn more about whether Neurocrine Biosciences, Inc. or Twist Bioscience Corporation is a better investment based on AAII's ...

Learn more about whether Amarin Corporation plc or Twist Bioscience Corporation is a better investment based on AAII's A+ ...

March 27, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics ..

This study provides valuable findings on the role of site-specific DNA methylation changes during spermatogenesis and their contribution to paternal epigenetic inheritance. The study proposes that ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

"In our lab, we study a protein called TBX2, a transcription factor (a protein that helps to convert DNA into RNA) that regulates the expression ... and more effective treatment strategy. "Our next ...

Integrator functions as a genome-wide attenuator of transcription that acts on elongation through its RNA cleavage and phosphatase modules ... Finish concentrating virus by following steps detailed in ...